Keratitis could be a condition during which the eye's tissue layer, the front a part of the attention, becomes inflamed. The condition is commonly marked by moderate to intense pain and requently involves any of the subsequent symptoms: pain, impaired sight, photophobia, red eye and a 'gritty' sensation.
Treatment of Keratitis depends on the cause of the keratitis. Infectious keratitis can progress rapidly, and generally requires urgent antibacterial, antifungal, or antiviral therapy to eliminate the pathogen. Antibacterial solutions include levofloxacin, gatifloxacin, moxifloxacin, ofloxacin.
The estimated annualised incidence of microbial keratitis was 1.1 per 10,000 (95% CI 0.6-1.7) users of daily-wear rigid gas-permeable lenses, 3.5 per 10,000 (2.7-4.5) users of daily-wear soft lenses, and 20.0 per 10,000 (10.3-35.0) users of extended-wear soft lenses (p<0.00001 for comparison between all groups), Five of the 92 patients achieved a final visual acuity of 20/70 or less. Ongoing Research is being done at Keratitis Centers